Effects of a novel histamine H2‐receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa
- 2 October 2007
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 22 (11), 1800-1805
- https://doi.org/10.1111/j.1440-1746.2006.04721.x
Abstract
Background and Aim: Lafutidine is a novel histamine H2‐receptor antagonist used primarily as an antisecretory agent in Japan. Previous human studies have not assessed its gastroprotective effects. The purpose of the present study was to determine the effects of lafutidine on the human gastric mucus layer using both histological and biochemical methods. Methods: Of the 14 patients scheduled for gastrectomy who consented to participate, seven were given 14 days of lafutidine 20 mg/day (lafutidine group) and the others received no medication (control group). The surface mucus gel layer in Carnoy‐fixed tissue sections was examined immunohistochemically. Both the thickness of the mucus layer and its mucin content were measured in gastric corpus mucosa. Results: There was no detectable difference between the groups in the grade of gastritis or the immunohistochemical staining characteristics. The laminated structure of the surface mucus gel layer was retained after administration of lafutidine and it was thicker than the layer in the control group. The surface layer in the lafutidine group had three‐fold more mucin than that in the control group. There was no difference between the two groups in the mucin content of the deep mucosa. Conclusion: Lafutidine, given at clinical dosages, not only inhibits acid secretion but also strengthens the mucus barrier of the human gastric mucosa.Keywords
This publication has 27 references indexed in Scilit:
- Effect of lafutidine, a novel histamine H2‐receptor antagonist, on monochloramine‐induced gastric lesions in rats: Role of capsaicin‐sensitive sensory neuronsJournal of Gastroenterology and Hepatology, 1999
- Classification and Grading of GastritisThe American Journal of Surgical Pathology, 1996
- Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogsEuropean Journal of Pharmacology, 1996
- Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damageLife Sciences, 1994
- Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomachEuropean Journal of Pharmacology, 1994
- Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogsEuropean Journal of Pharmacology, 1993
- Alternating laminated array of two types of mucin in the human gastric surface mucous layerJournal of Molecular Histology, 1992
- A dual staining method for identifying mucins of different gastric epithelial mucous cellsJournal of Molecular Histology, 1991
- Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats.Gut, 1980
- Definition and Antagonism of Histamine H2-receptorsNature, 1972